Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward?

IF 2.9 4区 医学 Q2 INFECTIOUS DISEASES
Victor Gerber , Louis Boehn , Marcela Sabou , Antoine Studer , Axel Ursenbach , Yves Hansmann , Raoul Herbrecht , Nicolas Lefebvre , Valérie Letscher-Bru , François Danion
{"title":"Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward?","authors":"Victor Gerber ,&nbsp;Louis Boehn ,&nbsp;Marcela Sabou ,&nbsp;Antoine Studer ,&nbsp;Axel Ursenbach ,&nbsp;Yves Hansmann ,&nbsp;Raoul Herbrecht ,&nbsp;Nicolas Lefebvre ,&nbsp;Valérie Letscher-Bru ,&nbsp;François Danion","doi":"10.1016/j.idnow.2024.104918","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>We evaluated the interest of systematic screening of serum fungal markers in patients hospitalized in a medical ward.</p></div><div><h3>Methods</h3><p>We retrospectively analyzed all patients hospitalized in our infectious disease department from October 1st to October 31st, 2020 for COVID-19 without prior ICU admission, and for whom systematic screening of serum fungal markers was performed.</p></div><div><h3>Results</h3><p>Thirty patients were included. The majority of patients received corticosteroids (96.7%). The galactomannan antigen assay was positive for 1/30 patients at D0, and 0/24, 0/16, 0/13 and 0/2 at D4, D7, D10 and D14 respectively. 1,3-ß-D-glucan was positive for 0/30, 1/24, 1/12, 0/12, 0/2 at D0, D4, D7, D10 and D14 respectively. No <em>Aspergillus fumigatus</em> PCR was positive. No cases of aspergillosis were retained.</p></div><div><h3>Conclusion</h3><p>Our study does not support the interest of systematic screening of fungal markers in immunocompetent patients with COVID-19 in a conventional unit.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000757/pdfft?md5=6625c2ae90df49374a4facefa0017fee&pid=1-s2.0-S2666991924000757-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases now","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666991924000757","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

We evaluated the interest of systematic screening of serum fungal markers in patients hospitalized in a medical ward.

Methods

We retrospectively analyzed all patients hospitalized in our infectious disease department from October 1st to October 31st, 2020 for COVID-19 without prior ICU admission, and for whom systematic screening of serum fungal markers was performed.

Results

Thirty patients were included. The majority of patients received corticosteroids (96.7%). The galactomannan antigen assay was positive for 1/30 patients at D0, and 0/24, 0/16, 0/13 and 0/2 at D4, D7, D10 and D14 respectively. 1,3-ß-D-glucan was positive for 0/30, 1/24, 1/12, 0/12, 0/2 at D0, D4, D7, D10 and D14 respectively. No Aspergillus fumigatus PCR was positive. No cases of aspergillosis were retained.

Conclusion

Our study does not support the interest of systematic screening of fungal markers in immunocompetent patients with COVID-19 in a conventional unit.

在内科病房对 COVID-19 患者进行系统的曲霉菌病血清筛查是否有意义?
方法 我们回顾性分析了 2020 年 10 月 1 日至 10 月 31 日期间因 COVID-19 在我院感染性疾病科住院的所有患者,这些患者事先未入住 ICU,并对其进行了血清真菌标志物系统筛查。大多数患者接受了皮质类固醇治疗(96.7%)。半乳甘露聚糖抗原检测在 D0 时有 1/30 患者呈阳性,在 D4、D7、D10 和 D14 时分别为 0/24、0/16、0/13 和 0/2。1,3-ß-D-葡聚糖在 D0、D4、D7、D10 和 D14 时分别有 0/30、1/24、1/12、0/12 和 0/2 呈阳性。没有曲霉菌 PCR 呈阳性。结论:我们的研究并不支持在常规病房对免疫功能正常的 COVID-19 患者进行系统的真菌标记物筛查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infectious diseases now
Infectious diseases now Medicine-Infectious Diseases
CiteScore
7.10
自引率
2.90%
发文量
116
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信